My point is the US doesn’t have a “pending decision” on AstraZeneca, the US has the potential (uncertain for many reasons) that they might apply at some time in the future.
Of course, AZ also lost its production capacity even if it was going to be approved, since it was dependent on the troubled Emergent facility which has been taken over but J&J and dedicated exclusively tonthe J&J vaccine, and has not located new production facilities.
Of course, AZ also lost its production capacity even if it was going to be approved, since it was dependent on the troubled Emergent facility which has been taken over but J&J and dedicated exclusively tonthe J&J vaccine, and has not located new production facilities.